Wednesday, 26 August 2026European Markets

HYDROGENPRO Stock Bullish Momentum With A 10.04% Jump Today

Loading stream...

(VIANEWS) - The Market ended the session with HYDROGENPRO (HYPRO.OL) rising 10.04% to kr27.40 on Thursday, following the last session's upward trend. Oslo Børs Benchmark Index_GI fell 0.5% to kr1,214.60, following the last session's downward trend on what was a somewhat bearish trend trading session today.

HYDROGENPRO's last close was kr24.90, 37.91% below its 52-week high of kr40.10.

About HYDROGENPRO

HydrogenPro AS designs and supplies customized hydrogen plants for industrial clients. The company primarily provides alkaline high-pressure electrolysers. It also offers containerized solutions for small plants; and indoor installations for medium plants. The company was incorporated in 2013 and is headquartered in Porsgrunn, Norway.

Earnings Per Share

As for profitability, HYDROGENPRO has a trailing twelve months EPS of kr-1.52.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is negative -19.14%.

Moving Average

HYDROGENPRO's worth is under its 50-day moving average of kr28.22 and below its 200-day moving average of kr28.43.

Volatility

HYDROGENPRO's last week, last month's, and last quarter's current intraday variation average was a positive 1.33%, a negative 0.23%, and a positive 2.72%.

HYDROGENPRO's highest amplitude of average volatility was 3.05% (last week), 3.04% (last month), and 2.72% (last quarter).

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, HYDROGENPRO's stock is considered to be oversold (<=20).

More news about HYDROGENPRO (HYPRO.OL).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Query this data → isubstrate.com